Category Archives: Events


Unifying Applications to Drive Effectiveness, Efficiency and Compliant Collaboration

By: Sandra K. Rodriguez, Market Analyst

Using a Cloud Platform to Connect the Life Science Value Chain

Pharmaceutical, Bio-Tech and Medical Device companies are increasingly adopting cloud platforms to drive effectiveness and efficiency throughout the value chain.  These organizations are unifying applications that support the total product lifecycle in a compliant manner, without losing sight of what matters most – product quality.

This shift from disconnected point solutions to a platform approach became clear at the Veeva Systems Global Summit for Clinical, Regulatory, and Quality in Philadelphia on October 17-19, 2016, where I joined over 600 attendees representing 154 companies.  Client presentations ranged from start-up to multi-national Life-Science companies including Regeneron, Shire and Johnson & Johnson. A list of presenters can be found here.

Jennifer Goldsmith, Senior Vice President, Veeva Vault

Jennifer Goldsmith, Senior Vice President, Veeva Vault

Jennifer Goldsmith, Senior Vice President, Veeva Vault kicked off the event by celebrating the five-year birthday of Vault.  This was my first time covering the event and I was immediately surprised by the opening keynote delivered by Peter Gassner, CEO at Veeva Systems.  He revealed that over the past three years, the company has consistently doubled its customer base across all three of its product offerings – Vault Clinical, Vault Quality and Vault Regulatory.  Sessions were offered across all three areas including a track on platforms and a focus on small and mid-size organizations. Continue reading


Hear Directly from FDA: Are You Done with UDI or Is This Just the Beginning?

Webinar Announcement 

Are you done with UDI… or is it just the beginning?  Hear directly from FDA’s Senior Advisor for UDI and Industry Experts the profound effect UDI implementation will have on Med-Tech manufacturers, healthcare providers, regulators and ultimately the patient.

On Oct. 13th at 1:30pm Eastern, join Terrie Reed, Senior Advisor for UDI Adoption at the FDADaniel R. Matlis of Axendia, and Jean Colombel of Dassault Systemes as they discuss UDI and how its value resides in the ability to optimize meaningful data collection and analysis.

Continue reading


Is IoT Vital to Well-Care?

By: Daniel R. Matlis, President

Improving Healthcare in the Outcome Economy

The Internet of Things (IoT) and the transition to the Outcome Economy were key themes at PTC’s LiveWorx16.  The focus on IoT and Product Lifecycle Management (PLM) and the shift to outcome based models, sparked this analysis on the applicability of these trends in our “sick-care system.”

The traditional healthcare model could better be described as “sick-care.”  Historically, healthcare has been episodic and reactive — primarily aimed at addressing a malady, illness or injury after it has already happened.

Here are a few examples:

  • Have a fever?                    →          Take an antipyretic.
  • Have an ache?                           Take an analgesic.
  • Have a damaged hip?                Have an arthroplasty.
  • Have angina?                              Have coronary artery bypass graft surgery.

This sick-care approach has it backwards, though. As the refrain goes, an ounce of prevention is worth a pound of cure. Furthermore, sick-care is expensive and unsustainable.  But, can we apply the IoT, PLM, and outcome-based models to healthcare? Continue reading


Webinar Announcement hosted by FDANews

Managing Quality and Compliance in a Global and Outsourced Ecosystem

Please join Axendia and Veeva Systems for a complimentary FDANews webinar on March 30th at 1:30 pm EDT.

Are suppliers and contract organizations putting your product’s quality at risk? Learn about industry trends and strategies your company can leverage to gain better control and visibility in our webinar.

Read More or Register to Attend



Shift is Happening Now

By Daniel R. Matlis, President

What Can Pharma CIOs do to Enable Innovation

What is the role of a CIO in a Pharma / Life-Science company?  Traditionally, the role of the CIO has been to manage the IT portfolio, implement systems, manage infrastructure and control IT costs to support the business.

With the unprecedented rate of shift the industry is experiencing, CIO’s can no longer simply be tasked with managing portfolios and budgets.

This was evident at the 2015 CIO Innovation Summit in Kyoto, Japan on October 20th.

There, Executives from leading organizations across the Life-Sciences ecosystem in Asia converged at the Ritz Carlton in Kyoto to learn about industry trends and share success stories and current best practices (cBPs).

Key themes at the event included innovation, transformation, collaboration and connectivity.  The event was hosted by BIOVIA – Dassault Systemes and brought together top executives from:

  • Astellas Pharma
  • Bridgestone
  • Bionet
  • Daichi Sankyo Biovia
  • Everlight Chemical
  • Genesis Genetics Asia
  • IPCA Laboratories
  • Samsung Biologics
  • Shionogi &Co
  • Sumitomo Danippon
  • Takeda Pharmaceuticals
  • Mitsui Chemicals
  • WuXi Apptech

Max Carnecchia, BIOVIA’s CEO, set the tone for the event in his opening remarks. His message: “By transforming the pharmaceutical industry through innovation, collaboration and connectivity, we can streamline end-to-end manufacturing, enhance quality and improve compliance in today’s challenging regulatory and risk environment.”

To learn more about illuminating dark data, please click here for a PDF copy of the entire Event Brief.